Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis? Lonergan R, Kinsella K, Kelly S, Duggan M, Scott J, O'Rourke K, Lynch T, Hutchinson M, Tubridy N, McGuigan C J Neurol Neurosurg Psychiatry. 2013 Nov; 84(11):e2. PMID: 24108958. Abstract CommentRecommendBookmarkWatch